
Avivagen Inc. – TSX:VIV.V
Avivagen stock price today
Avivagen key metrics
Market Cap | 388.47K |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | -0.05 |
Revenue | 715.21K |
EBITDA | -2.31M |
Income | -4.63M |
Revenue Q/Q | -16.62% |
Revenue Y/Y | -7.91% |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | -323.38% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeAvivagen stock price history
Avivagen stock forecast
Avivagen financial statements
Oct 2022 | 530.97K | -1.30M | -246.38% |
---|---|---|---|
Jan 2023 | 66.03K | -1.15M | -1747.35% |
Apr 2023 | 77.68K | -1.24M | -1602.45% |
Jul 2023 | 40.52K | -932.91K | -2302.08% |
Oct 2022 | 1365394 | 7.34M | 538.26% |
---|---|---|---|
Jan 2023 | 568302 | 7.67M | 1351.1% |
Apr 2023 | 324686 | 8.63M | 2658.96% |
Jul 2023 | 272532 | 9.53M | 3499.75% |
Oct 2022 | -732.31K | 0 | 528.73K |
---|---|---|---|
Jan 2023 | -130.32K | 0 | -133.76K |
Apr 2023 | 57.41K | 0 | -67.20K |
Jul 2023 | 71.51K | 1 | -71.21K |
Avivagen alternative data
Aug 2023 | 13 |
---|---|
Sep 2023 | 13 |
Oct 2023 | 13 |
Nov 2023 | 13 |
Dec 2023 | 13 |
Jan 2024 | 13 |
Feb 2024 | 13 |
Mar 2024 | 13 |
Apr 2024 | 13 |
May 2024 | 13 |
Jun 2024 | 13 |
Jul 2024 | 13 |
Avivagen other data
-
What's the price of Avivagen stock today?
One share of Avivagen stock can currently be purchased for approximately $0.07.
-
When is Avivagen's next earnings date?
Unfortunately, Avivagen's (VIV.V) next earnings date is currently unknown.
-
Does Avivagen pay dividends?
No, Avivagen does not pay dividends.
-
How much money does Avivagen make?
Avivagen has a market capitalization of 388.47K and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 27.53% to 939.17K US dollars.
-
What is Avivagen's stock symbol?
Avivagen Inc. is traded on the TSX under the ticker symbol "VIV.V".
-
What is Avivagen's primary industry?
Company operates in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry.
-
How do i buy shares of Avivagen?
Shares of Avivagen can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Avivagen have?
As Jul 2024, Avivagen employs 13 workers.
-
When Avivagen went public?
Avivagen Inc. is publicly traded company for more then 17 years since IPO on 25 Oct 2007.
-
What is Avivagen's official website?
The official website for Avivagen is avivagen.com.
-
Where are Avivagen's headquarters?
Avivagen is headquartered at 100 Sussex Drive, Ottawa, ON.
-
How can i contact Avivagen?
Avivagen's mailing address is 100 Sussex Drive, Ottawa, ON.
Avivagen company profile:

Avivagen Inc.
avivagen.comTSX
13
Drug Manufacturers—Specialty & Generic
Healthcare
Avivagen Inc., a life sciences company, focuses on developing and commercializing products for livestock feeds that support immune function and help animals to achieve their growth and productivity. The company offers OxC-beta Livestock, a premix for inclusion in livestock feeds; Vivamune health chews for dogs; Dr. Tobias dog chews; and Dr. Tobias Beta blend for the human immune system. It serves in the United States, Canada, the Philippines, Taiwan, Thailand, China, Mexico, Brazil, and Malaysia. Avivagen Inc. was incorporated in 2005 and is headquartered in Ottawa, Canada.
Ottawa, ON K1A 0R6
:
ISIN: CA05382F2026
: